Asthma and Allergies Impact America – PR Newswire (press release)


Cosmos

Asthma and Allergies Impact America
PR Newswire (press release)
WASHINGTON, May 2, 2011 /PRNewswire-USNewswire/ — Asthma and allergies are serious, life-threatening conditions that claim at least 10 lives a day and rack up costs in healthcare – including emergency department visits – and lost productivity.
New-age epidemicsKhaleej Times
Childhood eczema leads to adult allergic asthmaCosmos

all 8 news articles »

View full post on asthma – Google News

Thunderstorms, Pollen Spark Asthma Symptoms – Newswise (press release)

Thunderstorms, Pollen Spark Asthma Symptoms
Newswise (press release)
Newswise — The American College of Allergy, Asthma and Immunology (ACAAI) and the nation's allergists warn people with asthma to beware of both springtime blooms and thunderstorms which can trigger symptoms. Studies show an increase in asthma-related
When your pet makes you sneezeNewsChannel5.com
Beginning of spring means start of allergy seasonThe Seattle Times

all 14 news articles »

View full post on asthma – Google News

Everyone Breathe Launches New Asthma Education Grant Program to Raise … – Business Wire (press release)

Everyone Breathe Launches New Asthma Education Grant Program to Raise
Business Wire (press release)
(BUSINESS WIRE)–Everyone Breathe™ – an educational program geared toward raising awareness of asthma – launched a new initiative today in partnership with the Asthma and Allergy Foundation of America (AAFA) aimed at improving the quality of asthma
Beginning of spring means start of allergy seasonThe Seattle Times
Allergists Say Flood Water Can Make Air In Homes UnhealthyNewswise (press release)

all 8 news articles »

View full post on asthma – Google News

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for … – PR Newswire (press release)

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for
PR Newswire (press release)
Montelukast is FDA-approved for treatment of asthma and allergic rhinitis. It works by inhibiting leukotrienes, the chemicals that cause inflammation. Montelukast is considered a second line of defense against asthma or allergic rhinitis.

and more »

View full post on asthma – Google News

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for … – SYS-CON Media (press release)

Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for
SYS-CON Media (press release)
Montelukast is FDA-approved for treatment of asthma and allergic rhinitis. It works by inhibiting leukotrienes, the chemicals that cause inflammation. Montelukast is considered a second line of defense against asthma or allergic rhinitis.

View full post on asthma – Google News

Breakthrough In Allergic Asthma Treatments To Put Squeeze On Sneeze, UK – Medical News Today (press release)

Breakthrough In Allergic Asthma Treatments To Put Squeeze On Sneeze, UK
Medical News Today (press release)
A major breakthrough in creating effective new treatments for allergic asthma has been discovered by Asthma UK funded scientists at King's College London. The discovery is the culmination of over fifteen years of Asthma UK-funded research,

and more »

View full post on asthma – Google News